Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: A clinical feasibility study in comparison to CT and FDG-PET/CT

European Radiology

Volumn 24, Issue 4, 2014, Pages 889-901

  Michielsen, Katrijn ^a   Vergote, Ignace ^a   Op De Beeck, Katya ^a   Amant, Frederic ^a   Leunen, Karin ^a   Moerman, Philippe ^a   Deroose, Christophe ^a   Souverijns, Geert ^b   Dymarkowski, Steven ^a   De Keyzer, Frederik ^a   Vandecaveye, Vincent ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Department of Obstetrics and Gynaecology Leuven Cancer Institute University Hospitals Leuven ^*  (Belgium)

Author keywords

Diffusion weighted MRI; Gynaecologic surgical procedures; Ovarian cancer; Tumour staging; Whole body imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODIXANOL; MEGLUMINE IOXITALAMATE PLUS SODIUM IOXITALAMATE; SCOPOLAMINE BUTYL BROMIDE;

ACCURACY; ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOMATOSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DISTANT METASTASIS; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE GUIDED BIOPSY; LIVER METASTASIS; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MEDIASTINUM LYMPH NODE; MEDIASTINUM LYMPH NODE METASTASIS; MIDDLE AGED; NECK METASTASIS; OVARY CANCER; PELVIS; PERITONEAL CARCINOMATOSIS; PERITONEUM CANCER; PET SCANNER; PLEURA METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROPERITONEAL DISEASE; RETROPERITONEAL LYMPHADENOPATHY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; WHOLE BODY MRI; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DIFFUSION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE-GUIDED BIOPSY; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 84896317973     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-3083-8     Document Type: Article

References (49)

1. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765-781
2. Vergote I, Tropé CG, Amant F et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IVovarian cancer. N Engl J Med 363:943-953
3. Vergote I, De Wever I, Tjalma W, Van Gramberen M, Decloedt J, Van Dam P (1998) Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol 71:431-436 (Pubitemid 29022333)
4. Zivanovic O, Eisenhauer EL, Zhou Q et al (2008) The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecol Oncol 108:287-292 (Pubitemid 351174284)
5. Aletti GD, Dowdy SC, Podratz KC, Cliby WA (2006) Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol 100:283-287 (Pubitemid 43078481)
6. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248-1259 (Pubitemid 34177431)
7. Chi DS, Eisenhauer EL, Lang J et al (2006)What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103:559-564 (Pubitemid 44602167)
8. Du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzin. Cancer 115:1234-1244
9. Eisenkop SM, Friedman RL, Wang HJ (1998) Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 69:103-108 (Pubitemid 28246994)
10. Forstner R, Sala E, Kinkel K, Spencer JA (2010) ESUR guidelines: ovarian cancer staging and follow-up. Eur Radiol 20:2773-2780
11. Kumar D, Kand P, Basu S (2012) Impact of FDG-PET and -PET/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based appraoch. Womens Health 8:191-203
12. Kyriazi S, Kaye SB, deSouzaNM(2010) Imaging ovarian cancer and peritoneal metastases-current and emerging techniques.Nat Rev Clin Oncol 7:381-393
13. Vergote I, Van Gorp T, Amant F, Leunen K, Neven P, Berteloot P (2008) Timing of debulking surgery in advanced ovarian cancer. Int J Gynecol Cancer 18(Suppl 1):11-19 (Pubitemid 351389047)
14. Coakley FV, Choi PH, Gougoutas CA et al (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495-499 (Pubitemid 34454332)
15. Pannu HK, Bristow RE, Frederick J, Fishman EK (2003) Multidetector CT of peritoneal carcinomatosis from ovarian cancer. Radiographics 23:687-701 (Pubitemid 37431249)
16. Pannu HK, Horton KM, Fishman EK (2003) Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers. J Comput Assist Tomogr 27:333-340 (Pubitemid 36798083)
17. Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ (2000) Staging of advanced ovarian cancer: comparison of imaging modalities-report from the Radiological Diagnostic Oncology Group. Radiology 215:761-767 (Pubitemid 30346013)
18. Low RN, Barone RM (2012) Combined diffusion-weighted and gadolinium-enhancedMRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 19:1394-1401
19. Espada M, Garcia-Flores JR, Jimenez M et al (2013) Diffusion-weighted magnetic resonance imaging evaluation of intraabdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma. Eur Radiol 23:2636-2642
20. Heintz APM, Odicino F, Maisonneuve P et al (2006) Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95(Suppl 1):S161-S192
21. Timmerman D, Ameye L, Fischerova D et al (2010) Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 341:c6839-c6839
22. Vergote I, Du Bois A, Amant F, Heitz F, Leunen K, Harter P (2013) Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree? Gynecol Oncol 128:6-11
23. Arrivé L, Coudray C, Azizi L et al (2007) Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography]. [Article in French]. J Radiol 88:1689-1694 (Pubitemid 350261605)
24. Riordan RD (2004) Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography: a preliminary evaluation. Br J Radiol 77:991-999
25. Kolev V, Mironov S, Mironov O et al (2010) Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer. Int J Gynecol Cancer 20:979-984
26. Forstner R (2007) Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur Radiol 17:3223-3235
27. Kitajima K, Murakami K, Yamasaki E et al (2008) Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CTin staging ovarian cancer: comparison with enhanced CT. Eur J Nucl Med Mol Imaging 35:1912-1920
28. Thomassin-Naggara I, Toussaint I, Perrot N et al (2011) Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiology 258:793-803
29. Ohno Y, Koyama H, Yoshikawa T et al (2011) N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. Radiology 261:605-615
30. Kwee TC, Takahara T, Ochiai R, Nievelstein RAJ, Luijten PR (2008) Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18:1937-1952
31. Padhani AR, Liu G, Mu-koh D et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102-125
32. Low RN, Sebrechts CP, Barone RM, Muller W (2009) Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings-a feasibility study. AJR Am J Roentgenol 193:461-470
33. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72:1631-1636 (Pubitemid 23249290)
34. De Bree E,KoopsW, Kröger R,Van Ruth S,Witkamp AJ, Zoetmulder FAN (2004) Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86:64-73 (Pubitemid 38580516)
35. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu SVCM (2004) Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22:275-282 (Pubitemid 39264807)
36. Soussan M, Des Guetz G, Barrau Vet al (2012) Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy. Eur Radiol 22:1479-1487
37. Turlakow A, Yeung HW, Salmon AS, Macapinlac HA, Larson SM (2003) Peritoneal carcinomatosis: role of (18)F-FDG PET. J Nucl Med 44:1407-1412 (Pubitemid 39663352)
38. Yoshida Y, Kurokawa T, Kawahara K et al (2004) Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. AJR Am J Roentgenol 182:227-233 (Pubitemid 38017747)
39. Dirisamer A, Schima W, Heinisch M et al (2009) Detection of histologically proven peritoneal carcinomatosis with fused 18 F-FDG-PET/MDCT. Eur J Radiol 69:536-541
40. Kim HW,Won KS, Zeon SK, Ahn BC, Gayed IW (2013) Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18 F-FDG PET/CT. Clin Nucl Med 38:93-97
41. Pfannenberg AC, Aschoff P, Brechtel K et al (2007) Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging. Br J Radiol 80:437-445 (Pubitemid 47322230)
42. Satoh Y, Ichikawa T, Motosugi U et al (2011) Diagnosis of peritoneal dissemination: comparison of 18 F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AJR Am J Roentgenol 196:447-453
43. Nakai G,MatsukiM, InadaYet al (2008)Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging. J Comput Assist Tomogr 32:764-768
44. Klerkx WM, Heintz APM, Mali WPT et al (2009) Lymph node detection by MRI before and after a systematic pelvic lymphadenectomy. Gynecol Oncol 114:315-318
45. KlerkxWM,MaliWM, Heintz AP, De Kort GA, Takahara T, Peeters PH (2011) Observer variation of magnetic resonance imaging and diffusion weighted imaging in pelvic lymph node detection. Eur J Radiol 78:71-74
46. Kwee TC, Takahara T, Luijten PR, Nievelstein RAJ (2010) ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 75:215-220
47. Ohno Y, Hatabu H, Takenaka D et al (2004) Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 231:872-879 (Pubitemid 38668111)
48. Low RN (2009) Diffusion-weighted MR imaging for whole body metastatic disease and lymphadenopathy. Magn Reson Imaging Clin N Am 17:245-261
49. Hynninen J, Auranen A, Carpén O et al (2012) FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread. Gynecol Oncol 126:64-68